Drug Profile
Salmeterol/fluticasone propionate - DMK Pharmaceuticals
Alternative Names: APC 5000 DPI; APC-5000; Fluticasone propionate/salmeterol - DMK Pharmaceuticals; Salmeterol-xinafoate/fluticasone-propionateLatest Information Update: 13 Sep 2023
Price :
$50
*
At a glance
- Originator Adamis Pharmaceuticals Corporation
- Developer DMK Pharmaceuticals
- Class Androstadienes; Antiallergics; Antiasthmatics; Bronchodilators; Ethanolamines; Glucocorticoids; Phenethylamines; Small molecules
- Mechanism of Action Arachidonic acid inhibitors; Beta 2 adrenergic receptor agonists; Glucocorticoid receptor agonists; Lipocortin synthesis agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Asthma; Chronic obstructive pulmonary disease